Rosette has been a constraint to the production of groundnut in the existing farming system which contributes to the poor productivity of this crop. This trial was conducted in the screen-house of IITA Kano station, Nigeria to screen some groundnut varieties to rosette disease. The following parameters were measured during the trial such as chlorophyll content, plant vigor, disease incidence,50% day to flower and grain yield. The result showed that chlorophyll content of the varieties 19BT and ICGV-IS-07825 showed no significant difference in their measurement at 7 days after infestation. At 14 days 19BT, ICGV-IS-07825 and ICGV-IS-09011 measured low chlorophyll content and at 21 days after infestation the chlorophyll content of all the plants in the Trials measured slight difference. Slight difference was recorded in plant vigor for the spray Trial and the non-spray were almost the same 21 days after infestation. There was no disease incidence in the spray Trial. Four varieties 19BT, ICGV-IS-07825, ICGV-IS-08872 and ICGV-IS-09011 in the non-spray had highest disease incidence and ICGV-IS-09982 recorded least incidence. Number of first day and 50% day to flower was measured and the result showed that rosette does not have effect on flowering date of groundnut since the both Trial flowered at the same time. 19BT and ICGV-IS-08872 measured highest number in grains and pod weight. ICGV-IS-07825 and ICGV-IS-09982 measured least in number of grains and in pod weight in both Trials. It is concluded that resistance to groundnut rosette lutoevirus (GRVA) is not currently available in cultivated groundnut. More concerted effects are required where management packages can be put into proper practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.